HomeCompareACF vs JNJ

ACF vs JNJ: Dividend Comparison 2026

ACF yields 1250.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACF wins by $135327077.57M in total portfolio value
10 years
ACF
ACF
● Live price
1250.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$135327077.59M
Annual income
$116,926,161,071,848.38
Full ACF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ACF vs JNJ

📍 ACF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACF
Annual income on $10K today (after 15% tax)
$106,250.00/yr
After 10yr DRIP, annual income (after tax)
$99,387,236,911,071.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ACF beats the other by $99,387,236,910,367.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACF + JNJ for your $10,000?

ACF: 50%JNJ: 50%
100% JNJ50/50100% ACF
Portfolio after 10yr
$67663538.80M
Annual income
$58,463,080,536,338.08/yr
Blended yield
86.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACF buys
3
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
W. Gregory Steube🏢 House$ACF▲ Buy$15,001 - $50,0002025-07-10
Ro Khanna🏢 House$ACF▼ Sell$1,001 - $15,0002023-07-13
Ro Khanna🏢 House$ACF▼ Sell$1,001 - $15,0002023-06-28
William R. Keating🏢 House$ACF▼ Sell$15,001 - $50,0002023-06-27
Ro Khanna🏢 House$ACF▲ Buy$15,001 - $50,0002023-06-16
Ro Khanna🏢 House$ACF▲ Buy$1,001 - $15,0002023-04-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACFJNJ
Forward yield1250.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$135327077.59M$20.0K
Annual income after 10y$116,926,161,071,848.38$827.78
Total dividends collected$133960810.96M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACF vs JNJ ($10,000, DRIP)

YearACF PortfolioACF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$135,700$125,000.00$10,676$355.77+$125.0KACF
2$1,730,479$1,585,280.37$11,407$389.39+$1.72MACF
3$20,744,959$18,893,346.29$12,198$426.53+$20.73MACF
4$233,872,934$211,675,827.14$13,056$467.62+$233.86MACF
5$2,480,500,804$2,230,256,765.05$13,987$513.12+$2480.49MACF
6$24,761,170,753$22,107,034,892.35$14,998$563.56+$24761.16MACF
7$232,737,122,500$206,242,669,794.36$16,098$619.52+$232737.11MACF
8$2,060,741,008,119$1,811,712,287,044.72$17,295$681.69+$2060740.99MACF
9$17,197,118,239,637$14,992,125,360,949.39$18,599$750.82+$17197118.22MACF
10$135,327,077,588,260$116,926,161,071,848.38$20,022$827.78+$135327077.57MACF

ACF vs JNJ: Complete Analysis 2026

ACFStock

ACF is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ACF shares.

Full ACF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ACF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACF vs SCHDACF vs JEPIACF vs OACF vs KOACF vs MAINACF vs ABBVACF vs MRKACF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.